Sirt4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity
Yuxuan Luo(Guangzhou Women and Children Medical Center), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xizhou An(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofeng Chen(Changsha University of Science and Technology), Xiang Zhao(Shanghai East Hospital), Xuemin Xie, Xiaoqiang Tang(Sichuan University), De‐Long Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hou‐Zao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 242
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
|Circulation Research|2020|767
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
|Cardiovascular Research|2008|388
Biomarkers of aging
|Science China Life Sciences|2023|362
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
|Circulation|2017|353